| History and Research |
| The Problems And Limitations of Pharmaceutical Antibiotics Simply stated, the problem is Multiple Drug Resistant (MDR) strains of bacteria are becoming commonplace. Within five years of the widespread use of penicillin after World War II, scientists were discovering that bacteria such as Staphylococcus were developing a resistance to penicillin. Drug companies have poured millions of dollars into new research during the 60s, 70s, and 80s, to develop new antibiotics which could overcome these resistant strains. It appears that every disease-causing bacterium has strains that can resist at least one, if not most of pharmaceuticals' antibiotics. The prophylactic overuse of drug antibiotics is giving life to the spread of mutant microbes. Since the 1970s, various studies have concluded that 50 to 60 percent of all outpatient antibiotic prescriptions are inappropriate. Other studies have found that seven in ten Americans receive antibiotics when they seek treatment for common colds. Dr. Lee Green of Family Practitioners at the University of Michigan states, "We have a tradition of prescribing antibiotics to anybody who looks sick." As a result of the overuse of antibiotics, sales have nearly doubled since the mid 1980s. Likewise, drug-resistant infections have also increased. Bacterial tests are not covered in many insurance policies, encouraging doctors to make sloppy diagnosis. Drug companies encourage the situation by promotion of their products through extensive advertising and providing doctors with free samples. Adding to the dilemma is the fact that many patients do not use the antibiotics their doctors prescribe in accordance with the doctor's instruction. Many stop taking their medication after just a few days when it has killed many of the most susceptible microbes, leaving hardened bacterial survivors to flourish. Aside from being harder to treat, the resistant microbes can actually spread their immunity to different bacteria! An already serious problem is compounded when many patients save their unused drugs for later use . Recently, Dr. Thomas Beam of the Buffalo, New York VA Medical Center, summarized this health dilemma completely when he stated, "RESISTANT INFECTIONS ARE PRESENT IN EVERY HOSPITAL AND NURSING HOME." Super bugs are scattered everywhere including hospitals. No one has an exclusive on them. Patients are being stricken with drug resistant Staphylococcus Aureus, a bacteria that infects surgical wounds and can cause pneumonia and systemic blood infections. The Los Angeles Times stated on October 23, 1994 that "in the last decade, a broad resistance to antibiotics has begun to emerge. And because bacteria can transfer genes among themselves, experts only expect the resistance to grow. The potential nightmare is an Andromeda strain, which is immune to all antibiotics and could wreak havoc." (article, Arsenal of Antibiotics Failing as Resistant Bacteria Develop). Drugs such as penicillin and tetracycline lost their power over staph in the 50s and 60s. Methicilllin, another antibiotic, is now experiencing resistance. It was recently reported that in some 20 percent of nation's gonorrhea is now resistant to one or more antibiotics. A startling proportion of TB now resists the drug, Isoniazid. There is an enormous health crisis in the making, and pharmaceutical antibiotics do not hold the answer. It is blatantly obvious to anyone who does research on this subject that new emerging diseases and super bugs (not to mention the threat of biological attack from terrorist groups) are more of a threat now than ever before. Colloidal Silver can provide people with additional, non-prescriptive immunity armor to protect themselves. And unlike pharmaceutical drugs, no pathogen has ever develop a resistance to Colloidal Silver. THE EVER INCREASING THREAT OF “SUPER BUGS” While having gone unnoticed by a large portion of the population, there are numerous new emerging diseases which are beginning to manifest themselves with greater and greater frequency at ever widening locations across the country. In addition to this, the threat of biological attack from nations such as Iraq, as well as various terrorist groups has become increasingly prominent. Recently, news stories about terrorists using biological agents like Anthrax, to emerging diseases such as Flesh-Eating Bacteria, Multiple Drug Resistant Staph, Hanta Virus, Mad Cow Disease, Pfiesteria ("Red Tide"), Meningitis, Australian Flu, Bird Flu, E-coli, etc. have become commonplace. Moreover, diseases that we were previously controllable with pharmaceutical antibiotics are adapting themselves and becoming resistant to virtually all of our pharmaceutical drugs. A good example is the dangerous strain of the common staph germ, Staphylococcus aureus. It now has doctors worried because it has developed a resistance to pharmaceuticals' most powerful antibiotic, Vancomycin (CNN May 28, Aug 22, & Sept 5, 1997). The percentage of Staphylococci infections resistant to penicillin in 1960 was 13; the percentage resistant in 1997 was 99. Clearly, a non-pharmaceutical solution is required. Unfortunately, while some television shows, such as Dateline and Nova, have examined the issue of emerging diseases, the true extent of the danger is barely perceived by the public. The problem goes unnoticed, so more and more people remain unaware, unprotected, and vulnerable. ARGYRIA Blue/Grey skin Proponents of pharmaceuticals have attempted to debunk the use of Colloidal Silver based on a fraudulent claim that Colloidal Silver can cause Argyria, a rare condition that results in a bluish/grey tinting of the skin. What these debunkers fail to mention is that all known cases of Argyria are due to long-term consumption of low grade/large particulate solutions and systemic absorption of silver compounds, usually in the form of protein compounds . Colloidal Silver is silver in its elemental form. The body does not store excess elemental silver, but rather eliminates it, as with other heavy metals, via the metallothioneins. These ubiquitous proteins bind heavy metals into metal-thiolate-cluster complexes and remove them from the body. |

